BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today announced two key hires to accelerate its translational drug development efforts. It follows the closing of an oversubscribed $51M Series A financing round in June. Narayanan (Hari) Hariharan, MSc, Ph.D., has joined as Senior Vice President of Discovery Biology and Translational Sciences, alongside Indranil Mukhopa